{
  "@context": "https://tradecompliancerecords.com/schemas/v2/regulation.json",
  "schema_version": "2.2.0",
  "open_data": true,
  "ai_optimized": true,
  "slug": "eu-drug-precursors-regulation",
  "name": "EU Drug Precursors Regulation 273/2004",
  "authority": "European Commission",
  "region": "Europe",
  "cluster": "Chemical Controls",
  "wikidata_qid": null,
  "wikidata_entity": null,
  "wikipedia_article": null,
  "official_source_url": "https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32004R0273",
  "gov_entry_url": null,
  "document_types": "Regulation",
  "key_obligations": "Licensing; registration; customer declaration; suspicious transaction reporting; import/export",
  "enforcement_bodies": "European Commission; national competent authorities",
  "penalty_ranges": null,
  "affected_hs_codes": null,
  "mandatory_deadline": null,
  "applicability_scope": null,
  "cryptographic_integrity": {
    "sha256_hash": "e36e5c8a882ff8810b7cd9c74d3f64ad7455c95c90f4ba177fd49a68cb4b0f4a",
    "hash_algorithm": "SHA-256",
    "status": "cryptographically_hardened",
    "source_document_verified": true,
    "provenance": "source_document",
    "provenance_note": "SHA-256 derived from an ingested source document.",
    "r2_key": "regulations/eu-drug-precursors-regulation/eu-drug-precursors-regulation.html",
    "pdf_url": "https://tcr-vault.tradecompliancerecords.com/regulations/eu-drug-precursors-regulation/eu-drug-precursors-regulation.html",
    "file_size_bytes": 2035,
    "version_date": "2026-05-25",
    "last_verified_at": "2026-05-25T12:01:53.556Z"
  },
  "operational_consequences": null,
  "logistical_liability_exposure": false,
  "verification_consensus_score": "100%",
  "verification_notes": null,
  "tcr_authority_page": "https://tradecompliancerecords.com/wiki/eu-drug-precursors-regulation",
  "created_at": "2026-05-20 19:22:50",
  "infographic_r2_key": null,
  "infographic_sha256_hash": null,
  "infographic_generated_at": 1786350643311,
  "infographic_approved": 0,
  "origin_problem": "FACTUAL: 2003 illegal drug trade increase in Europe highlighted lack of controls on chemical precursors.",
  "problem_statement": "HEADLINE: Unregulated chemical precursors fueled illegal drug production in Europe.",
  "pre_regulation_status_quo": "FACTUAL: No EU-wide licensing or registration for chemical precursors. Limited national controls existed.",
  "operational_pain_points": [
    "Licensing requirement: All operators must obtain licenses for listed substances (Article 3).",
    "Customer declaration: Mandatory for all transactions involving scheduled substances (Article 4).",
    "Suspicious transaction reporting: Must report within 24 hours of identification (Article 9).",
    "Import/export controls: Requires prior authorization for all cross-border movements (Article 12).",
    "Record-keeping: Minimum 3-year retention for all transaction records (Article 5)."
  ],
  "search_intent_tree": null,
  "paa_questions": [
    {
      "q": "What are the penalties for non-compliance with EU Drug Precursors Regulation 273/2004?",
      "a": "• Max penalty: Not publicly specified\n• Trigger: Non-reporting of suspicious transactions (Article 9)\n• Enforcement body: National competent authorities\n• First offence vs repeat: Not publicly specified"
    },
    {
      "q": "Who must comply with EU Drug Precursors Regulation 273/2004?",
      "a": "• Threshold: Not publicly specified\n• Entity types: Manufacturers, importers, distributors\n• Exemptions: Not publicly specified\n• Geographic scope: EU member states"
    },
    {
      "q": "What is the compliance deadline for EU Drug Precursors Regulation 273/2004?",
      "a": "• Phase 1 deadline: Not publicly specified\n• Phase 2 deadline: Not publicly specified\n• Transitional period: Not publicly specified\n• Enforcement start: 2005"
    },
    {
      "q": "What documents are required for EU Drug Precursors Regulation 273/2004 compliance?",
      "a": "• License: Authorization to handle precursors (Article 3)\n• Customer declaration: Verification of end-use (Article 4)\n• Retention period: 3 years\n• Submission format: Electronic or paper"
    },
    {
      "q": "How does EU Drug Precursors Regulation 273/2004 affect importers?",
      "a": "• Import authorization: Required for all precursor imports (Article 12)\n• Customs declaration requirement: Mandatory for all shipments\n• Due diligence or traceability requirement: Not publicly specified\n• Cost estimate: Not publicly specified"
    },
    {
      "q": "What is the enforcement mechanism for EU Drug Precursors Regulation 273/2004?",
      "a": "• Primary enforcer: National competent authorities\n• Investigation trigger: Suspicious transaction reports\n• Appeal process: Not publicly specified\n• Cross-border coordination: Not publicly specified"
    },
    {
      "q": "Are there exemptions under EU Drug Precursors Regulation 273/2004?",
      "a": "• SME exemption: Not publicly specified\n• Sector exclusions: Not publicly specified\n• Transitional exemptions: Not publicly specified\n• Article reference: Not publicly specified"
    },
    {
      "q": "How does EU Drug Precursors Regulation 273/2004 interact with other regulations?",
      "a": "• Overlaps with: EU Regulation 111/2005\n• Conflicts with: Not publicly specified\n• Supersedes: Not publicly specified\n• Mutual recognition: Not publicly specified"
    },
    {
      "q": "What supply chain traceability does EU Drug Precursors Regulation 273/2004 require?",
      "a": "• Tier depth: Not publicly specified\n• Data fields required: Not publicly specified\n• Technology standard: Not publicly specified\n• Audit frequency: Not publicly specified"
    },
    {
      "q": "What is the cost of EU Drug Precursors Regulation 273/2004 compliance for a mid-size company?",
      "a": "• Implementation cost: Not publicly specified\n• Annual compliance cost: Not publicly specified\n• Penalty risk: Not publicly specified\n• Source: Not publicly specified"
    }
  ],
  "enrichment_status": "enriched"
}